Indeed, since 2010, the task force of the Galveston International Congress on APS recommends testing for the IgA isotype (anti-CL and anti-β2GPI) in patients with clinical criteria of APS and with persistently negative aPL included in the classification criteria [35]. This evidence concerns the gene CD79A and autoimmune polyendocrinopathy.